111 related articles for article (PubMed ID: 10637452)
1. Increased level and duration of expression in muscle by co-expression of a transactivator using plasmid systems.
Li S; MacLaughlin FC; Fewell JG; Li Y; Mehta V; French MF; Nordstrom JL; Coleman M; Belagali NS; Schwartz RJ; Smith LC
Gene Ther; 1999 Dec; 6(12):2005-11. PubMed ID: 10637452
[TBL] [Abstract][Full Text] [Related]
2. Sustained expression after nonviral ocular gene transfer using mammalian promoters.
Kachi S; Esumi N; Zack DJ; Campochiaro PA
Gene Ther; 2006 May; 13(9):798-804. PubMed ID: 16467860
[TBL] [Abstract][Full Text] [Related]
3. Muscle-specific enhancement of gene expression by incorporation of SV40 enhancer in the expression plasmid.
Li S; MacLaughlin FC; Fewell JG; Gondo M; Wang J; Nicol F; Dean DA; Smith LC
Gene Ther; 2001 Mar; 8(6):494-7. PubMed ID: 11313829
[TBL] [Abstract][Full Text] [Related]
4. Avian serum response factor expression restricted primarily to muscle cell lineages is required for alpha-actin gene transcription.
Croissant JD; Kim JH; Eichele G; Goering L; Lough J; Prywes R; Schwartz RJ
Dev Biol; 1996 Jul; 177(1):250-64. PubMed ID: 8660892
[TBL] [Abstract][Full Text] [Related]
5. CMV enhancer/human PDGF-beta promoter for neuron-specific transgene expression.
Liu BH; Wang X; Ma YX; Wang S
Gene Ther; 2004 Jan; 11(1):52-60. PubMed ID: 14681697
[TBL] [Abstract][Full Text] [Related]
6. Comparison of promoter region constructs for in vivo intramuscular expression.
Fabre EE; Bigey P; Orsini C; Scherman D
J Gene Med; 2006 May; 8(5):636-45. PubMed ID: 16477670
[TBL] [Abstract][Full Text] [Related]
7. Adenoviral-mediated skeletal muscle transcriptional targeting using chimeric tissue-specific promoters.
Frauli M; Ribault S; Neuville P; Augé F; Calenda V
Med Sci Monit; 2003 Feb; 9(2):BR78-84. PubMed ID: 12601283
[TBL] [Abstract][Full Text] [Related]
8. Gene expression in rainbow trout (Oncorhynchus mykiss) following intramuscular injection of DNA.
Anderson ED; Mourich DV; Leong JA
Mol Mar Biol Biotechnol; 1996 Jun; 5(2):105-13. PubMed ID: 8680523
[TBL] [Abstract][Full Text] [Related]
9. Promoter- and strain-selective enhancement of gene expression in a mouse skeletal muscle by a polymer excipient Pluronic P85.
Yang Z; Zhu J; Sriadibhatla S; Gebhart C; Alakhov V; Kabanov A
J Control Release; 2005 Nov; 108(2-3):496-512. PubMed ID: 16154658
[TBL] [Abstract][Full Text] [Related]
10. Synthetic muscle promoters: activities exceeding naturally occurring regulatory sequences.
Li X; Eastman EM; Schwartz RJ; Draghia-Akli R
Nat Biotechnol; 1999 Mar; 17(3):241-5. PubMed ID: 10096290
[TBL] [Abstract][Full Text] [Related]
11. Increased persistence of lung gene expression using plasmids containing the ubiquitin C or elongation factor 1alpha promoter.
Gill DR; Smyth SE; Goddard CA; Pringle IA; Higgins CF; Colledge WH; Hyde SC
Gene Ther; 2001 Oct; 8(20):1539-46. PubMed ID: 11704814
[TBL] [Abstract][Full Text] [Related]
12. Specific inhibition of skeletal alpha-actin gene transcription by applied mechanical forces through integrins and actin.
Lew AM; Glogauer M; Mculloch CA
Biochem J; 1999 Aug; 341 ( Pt 3)(Pt 3):647-53. PubMed ID: 10417328
[TBL] [Abstract][Full Text] [Related]
13. The combination of a synthetic promoter and a CMV promoter improves foreign gene expression efficiency in myocytes.
Jianwei D; Qianqian Z; Songcai L; Mingjun Z; Xiaohui R; Linlin H; Qingyan J; Yongliang Z
J Biotechnol; 2012 Apr; 158(3):91-6. PubMed ID: 22206980
[TBL] [Abstract][Full Text] [Related]
14. Construction and analysis of compact muscle-specific promoters for AAV vectors.
Wang B; Li J; Fu FH; Chen C; Zhu X; Zhou L; Jiang X; Xiao X
Gene Ther; 2008 Nov; 15(22):1489-99. PubMed ID: 18563184
[TBL] [Abstract][Full Text] [Related]
15. Efficient gene transfer into zebrafish skeletal muscle by intramuscular injection of plasmid DNA.
Tan JH; Chan WK
Mol Mar Biol Biotechnol; 1997 Jun; 6(2):98-109. PubMed ID: 9200836
[TBL] [Abstract][Full Text] [Related]
16. Lack of toxicity of alpha-sarcoglycan overexpression supports clinical gene transfer trial in LGMD2D.
Rodino-Klapac LR; Lee JS; Mulligan RC; Clark KR; Mendell JR
Neurology; 2008 Jul; 71(4):240-7. PubMed ID: 18525034
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional silencing is associated with extensive methylation of the CMV promoter following adenoviral gene delivery to muscle.
Brooks AR; Harkins RN; Wang P; Qian HS; Liu P; Rubanyi GM
J Gene Med; 2004 Apr; 6(4):395-404. PubMed ID: 15079814
[TBL] [Abstract][Full Text] [Related]
18. Cre-loxP system as a versatile tool for conferring increased levels of tissue-specific gene expression from a weak promoter.
Nakamura S; Watanabe S; Ohtsuka M; Maehara T; Ishihara M; Yokomine T; Sato M
Mol Reprod Dev; 2008 Jun; 75(6):1085-93. PubMed ID: 18163444
[TBL] [Abstract][Full Text] [Related]
19. TEF-1 and MEF2 transcription factors interact to regulate muscle-specific promoters.
Maeda T; Gupta MP; Stewart AF
Biochem Biophys Res Commun; 2002 Jun; 294(4):791-7. PubMed ID: 12061776
[TBL] [Abstract][Full Text] [Related]
20. Prostate-specific antigen promoter/enhancer driven gene therapy for prostate cancer: construction and testing of a tissue-specific adenovirus vector.
Latham JP; Searle PF; Mautner V; James ND
Cancer Res; 2000 Jan; 60(2):334-41. PubMed ID: 10667585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
